Aetna (AET) Shares Sold by Personal Capital Advisors Corp

Personal Capital Advisors Corp lowered its stake in Aetna (NYSE:AET) by 3.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 178,864 shares of the company’s stock after selling 5,865 shares during the quarter. Personal Capital Advisors Corp owned 0.05% of Aetna worth $30,228,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Gamco Investors INC. ET AL bought a new stake in shares of Aetna in the 1st quarter valued at $4,750,000. GABELLI & Co INVESTMENT ADVISERS INC. increased its stake in shares of Aetna by 1,240.4% in the 1st quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 150,800 shares of the company’s stock valued at $25,485,000 after acquiring an additional 139,550 shares in the last quarter. Gabelli Funds LLC increased its stake in shares of Aetna by 228.3% in the 1st quarter. Gabelli Funds LLC now owns 162,500 shares of the company’s stock valued at $27,463,000 after acquiring an additional 113,000 shares in the last quarter. Candriam Luxembourg S.C.A. increased its stake in Aetna by 104.2% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 57,982 shares of the company’s stock valued at $9,799,000 after purchasing an additional 29,586 shares in the last quarter. Finally, Palisade Capital Management LLC NJ increased its stake in Aetna by 54.3% during the 1st quarter. Palisade Capital Management LLC NJ now owns 55,818 shares of the company’s stock valued at $9,433,000 after purchasing an additional 19,653 shares in the last quarter. Institutional investors own 84.19% of the company’s stock.

Aetna opened at $177.72 on Tuesday, according to MarketBeat.com. Aetna has a 1 year low of $140.24 and a 1 year high of $194.40. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $57.83 billion, a PE ratio of 18.02, a PEG ratio of 1.49 and a beta of 0.64.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, May 1st. The company reported $3.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.97 by $0.22. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The firm had revenue of $15.34 billion during the quarter, compared to analyst estimates of $15.32 billion. During the same quarter in the prior year, the business posted $2.71 EPS. The business’s revenue was up 1.1% compared to the same quarter last year. analysts forecast that Aetna will post 11.06 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th will be paid a $0.50 dividend. The ex-dividend date is Tuesday, July 24th. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s payout ratio is 20.28%.

AET has been the subject of a number of recent research reports. Cowen restated a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Piper Jaffray Companies restated a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Deutsche Bank upgraded shares of Aetna from a “hold” rating to a “buy” rating and boosted their price target for the company from $195.00 to $212.00 in a research note on Monday, January 22nd. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Eight investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $196.36.

Aetna Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply